Allyson Perry, PhD, is currently a Senior Advisor and Clinical Research Scientist at Eli Lilly and Company, focusing on Medical Affairs in Global and US Rheumatology. Previously, they served as a Medical Director at DermTech, where they managed scientific communication initiatives for a melanoma rule-out test and led real-world studies. With over eight years of experience in the pharmaceutical and diagnostics industries and a PhD in Cancer Biology, Allyson has a strong background in oncology and immunology. They have authored multiple peer-reviewed publications and have successfully collaborated with key opinion leaders and cross-functional teams to enhance scientific communication and education. Allyson’s commitment to improving patient outcomes through evidence-based innovations underscores their passion for advancing the fields of oncology and immunology.
This person is not in any teams
This person is not in any offices